PP
AMED

PDT Partners’s Amedisys AMED Stock Holding History

PDT Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,065
Closed -$393K – 623
2022
Q3 		$393K Sell
4,065
-6,660
-62% -$794K 0.06% 502
2022
Q2 		$1.13M Buy
+10,725
New +$1.37M 0.1% 354
2021
Q4 		– Sell
-2,315
Closed -$345K – 860
2021
Q3 		$345K Buy
+2,315
New +$481K 0.02% 564
2020
Q1 		– Sell
-4,736
Closed -$791K – 655
2019
Q4 		$791K Sell
4,736
-37,642
-89% -$5.6M 0.05% 323
2019
Q3 		$5.55M Sell
42,378
-4,787
-10% -$623K 0.33% 114
2019
Q2 		$5.73M Buy
47,165
+14,200
+43% +$1.69M 0.34% 104
2019
Q1 		$4.06M Sell
32,965
-31,200
-49% -$3.92M 0.23% 130
2018
Q4 		$7.51M Buy
64,165
+29,700
+86% +$3.5M 0.42% 98
2018
Q3 		$4.31M Buy
34,465
+8,500
+33% +$939K 0.18% 151
2018
Q2 		$2.22M Sell
25,965
-14,800
-36% -$1.09M 0.08% 245
2018
Q1 		$2.46M Buy
+40,765
New +$2.32M 0.08% 245
2016
Q3 		– Sell
-4,731
Closed -$239K – 475
2016
Q2 		$239K Sell
4,731
-36,369
-88% -$1.84M 0.02% 391
2016
Q1 		$1.99M Sell
41,100
-300
-0.7% -$11.6K 0.12% 242
2015
Q4 		$1.63M Sell
41,400
-32,290
-44% -$1.29M 0.22% 164
2015
Q3 		$2.8M Buy
73,690
+25,895
+54% +$1.09M 0.06% 340
2015
Q2 		$1.9M Buy
47,795
+16,795
+54% +$523K 0.05% 449
2015
Q1 		$830K Buy
31,000
+6,100
+24% +$172K 0.02% 853
2014
Q4 		$731K Buy
+24,900
New +$615K 0.07% 395
2014
Q3 		– Sell
-18,554
Closed -$311K – 1280
2014
Q2 		$311K Buy
+18,554
New +$263K 0.01% 1185
2013
Q4 		– Sell
-102,552
Closed -$1.77M – 641
2013
Q3 		$1.77M Buy
+102,552
New +$1.52M 0.05% 541

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PDT Partners's AMED Position: Q4 2022 in Review

PDT Partners sold out of Amedisys (AMED) in Q4 2022, closing a stake of 4,065 shares — an estimated $393K sold.

PDT Partners first reported a position in AMED in Q3 2013 and held it in 20 quarters. The position peaked at $7.51M in Q4 2018. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • PDT Partners reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 4,065 Amedisys shares in Q4 2022, an estimated $393K.
  • PDT Partners first reported a position in Amedisys in Q3 2013 and held it in 20 quarters.
  • PDT Partners's Amedisys position peaked at $7.51M in Q4 2018.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.